Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment

Metabolites
Nuria Arias-RamosAna Paula Candiota

Abstract

Glioblastoma (GBM) is the most common aggressive primary brain tumor in adults, with a short survival time even after aggressive therapy. Non-invasive surrogate biomarkers of therapy response may be relevant for improving patient survival. Previous work produced such biomarkers in preclinical GBM using semi-supervised source extraction and single-slice Magnetic Resonance Spectroscopic Imaging (MRSI). Nevertheless, GBMs are heterogeneous and single-slice studies could prevent obtaining relevant information. The purpose of this work was to evaluate whether a multi-slice MRSI approach, acquiring consecutive grids across the tumor, is feasible for preclinical models and may produce additional insight into therapy response. Nosological images were analyzed pixel-by-pixel and a relative responding volume, the Tumor Responding Index (TRI), was defined to quantify response. Heterogeneous response levels were observed and treated animals were ascribed to three arbitrary predefined groups: high response (HR, n = 2), TRI = 68.2 ± 2.8%, intermediate response (IR, n = 6), TRI = 41.1 ± 4.2% and low response (LR, n = 2), TRI = 13.4 ± 14.3%, producing therapy response categorization which had not been fully registered in single-slice studies. ...Continue Reading

References

Jan 1, 1990·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·C M SegebarthJ A den Hollander
Jun 22, 2000·NMR in Biomedicine·V GovindarajuA A Maudsley
Feb 13, 2001·Journal of Magnetic Resonance Imaging : JMRI·T R McKnightS J Nelson
Mar 17, 2001·NMR in Biomedicine·I BarbaC Gasparovic
Jun 19, 2001·NMR in Biomedicine·S W Provencher
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jozsef KarmanZsuzsanna Fabry
Dec 9, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniel E HallBrian D Ross
Jul 22, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jie TangDavid W Andrews
Feb 8, 2006·Acta Neuropathologica·Arie Perry, Robert E Schmidt
Jun 30, 2007·NMR in Biomedicine·R V SimõesC Arús
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
Nov 21, 2009·IEEE Transactions on Pattern Analysis and Machine Intelligence·Chris DingMichael I Jordan
Aug 17, 2010·Neuroimaging Clinics of North America·Alena Horská, Peter B Barker
Mar 12, 2011·AJNR. American Journal of Neuroradiology·L C Hygino da CruzA G Sorensen
Dec 24, 2011·Integrative Biology : Quantitative Biosciences From Nano to Macro·Rui Vasco SimõesCarles Arús
Oct 31, 2012·PloS One·Sandra Ortega-MartorellCarles Arús
Mar 14, 2013·Oncoimmunology·Mouna TabbekhFathia Mami-Chouaib
Apr 3, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ilkka LiikanenAkseli Hemminki
Jul 31, 2013·Immunity·Daniel S Chen, Ira Mellman
Sep 17, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ying ZhengEtty N Benveniste
May 7, 2014·Oncoimmunology·Erika VacchelliLorenzo Galluzzi
Aug 27, 2014·Pathology Oncology Research : POR·Katalin Eder, Bernadette Kalman
Nov 8, 2014·Neoplasia : an International Journal for Oncology Research·Luis MarreroOm Prakash
Jan 28, 2015·Scientific Reports·Akio SoedaDeric M Park

❮ Previous
Next ❯

Methods Mentioned

BETA
NMR
nuclear magnetic resonance

Software Mentioned

NDPview
Linux
ARRIVE
ParaVision
LCModel
MatLab
Interactive Chemical Shift Imaging ( 3DiCSI )
UNIANOVA

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.